This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Mochida Pharmaceutical Co., Ltd.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Naoya Yoshioka: Innovator in Freeze-Dried Alginic Acid Preparation
Introduction
Naoya Yoshioka is a notable inventor based in Fujieda, Japan. He has made significant contributions to the field of freeze-dried compositions, particularly focusing on alginic acid preparations. His work has led to advancements that enhance the stability and usability of these compositions.
Latest Patents
Yoshioka holds 2 patents related to freeze-dried alginic acid preparation. His latest patents describe a freeze-dried composition that includes a monovalent metal alginate and a salt selected from a monovalent metal salt and an ammonium salt. The method of producing this composition involves freezing an aqueous solution formed by dissolving these components, followed by a two-step drying process to reduce the water content to 3% by mass or less. This innovative approach results in a freeze-dried monovalent metal alginate composition that maintains its viscosity over time.
Career Highlights
Yoshioka is currently associated with Mochida Pharmaceutical Co., Ltd., where he continues to develop and refine his inventions. His work is instrumental in advancing pharmaceutical applications of alginic acid, contributing to the field's growth and innovation.
Collaborations
Yoshioka collaborates with Shuichi Endo, enhancing the research and development efforts within their projects. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Naoya Yoshioka's contributions to freeze-dried alginic acid preparation highlight his role as a key inventor in this specialized field. His patents and ongoing work at Mochida Pharmaceutical Co., Ltd. demonstrate his commitment to advancing pharmaceutical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile